| Primary |
| Product Used For Unknown Indication |
21.7% |
| Drug Use For Unknown Indication |
18.6% |
| Osteoarthritis |
6.8% |
| Back Pain |
5.6% |
| Pain |
5.6% |
| Diabetes Mellitus |
5.0% |
| Arthralgia |
4.3% |
| Arthritis |
4.3% |
| Completed Suicide |
3.7% |
| Neuralgia |
3.7% |
| Atrial Fibrillation |
2.5% |
| Bronchopulmonary Aspergillosis |
2.5% |
| Neck Pain |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Headache |
1.9% |
| Liver Disorder |
1.9% |
| Migraine |
1.9% |
| Skin Ulcer |
1.9% |
| Tension Headache |
1.9% |
| Diabetes Insipidus |
1.2% |
|
| Toxic Epidermal Necrolysis |
9.4% |
| Renal Failure Acute |
7.5% |
| Vomiting |
7.5% |
| Angioedema |
5.7% |
| Duodenal Ulcer |
5.7% |
| Gastritis Erosive |
5.7% |
| Renal Impairment |
5.7% |
| Somnolence |
5.7% |
| Thrombocytopenia |
5.7% |
| Anaemia |
3.8% |
| Asthenia |
3.8% |
| Drug Toxicity |
3.8% |
| Hepatic Steatosis |
3.8% |
| Leukocytoclastic Vasculitis |
3.8% |
| Melaena |
3.8% |
| Oedema Peripheral |
3.8% |
| Pallor |
3.8% |
| Pruritus |
3.8% |
| Stevens-johnson Syndrome |
3.8% |
| Syncope |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
29.4% |
| Drug Use For Unknown Indication |
9.9% |
| Rheumatoid Arthritis |
8.8% |
| Headache |
7.1% |
| Hypertension |
6.4% |
| Pain |
6.0% |
| Back Pain |
4.1% |
| Anaesthesia |
3.5% |
| Respiratory Disorder |
3.4% |
| Bone Disorder |
3.3% |
| Sciatica |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| Renal Transplant |
1.9% |
| Pyrexia |
1.8% |
| Infection |
1.7% |
| Constipation |
1.7% |
| Migraine |
1.6% |
| Premedication |
1.6% |
| Prophylaxis |
1.6% |
| Completed Suicide |
1.5% |
|
| Renal Failure Acute |
18.0% |
| Vomiting |
12.1% |
| Cytolytic Hepatitis |
7.5% |
| Urticaria |
6.7% |
| Liver Injury |
4.6% |
| Pyrexia |
4.6% |
| Thrombocytopenia |
4.6% |
| Stevens-johnson Syndrome |
4.2% |
| Drug Hypersensitivity |
3.8% |
| Hepatitis |
3.8% |
| Pruritus |
3.8% |
| Tracheobronchitis |
3.8% |
| Renal Failure |
3.3% |
| Acute Generalised Exanthematous Pustulosis |
2.9% |
| Angioedema |
2.9% |
| General Physical Health Deterioration |
2.9% |
| Weight Decreased |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.5% |
| Haematemesis |
2.5% |
| Maternal Exposure During Pregnancy |
2.5% |
|
| Concomitant |
| Rheumatoid Arthritis |
25.0% |
| Product Used For Unknown Indication |
16.1% |
| Drug Use For Unknown Indication |
12.3% |
| Prophylaxis |
8.7% |
| Hypertension |
5.9% |
| Pain |
4.6% |
| Back Pain |
3.6% |
| Constipation |
3.2% |
| Insomnia |
3.0% |
| Osteoporosis |
2.3% |
| Aplastic Anaemia |
2.3% |
| Anxiety |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Diabetes Mellitus |
1.5% |
| Infection Prophylaxis |
1.4% |
| Depression |
1.4% |
| Gastritis Prophylaxis |
1.4% |
| Gastritis |
1.2% |
| Osteoarthritis |
1.1% |
| Crohn's Disease |
1.1% |
|
| Vomiting |
14.9% |
| Pyrexia |
7.2% |
| Rheumatoid Arthritis |
7.0% |
| Breast Cancer |
6.6% |
| Pneumonia |
6.2% |
| Rash |
5.9% |
| White Blood Cell Count Decreased |
5.7% |
| Interstitial Lung Disease |
5.3% |
| Sepsis |
4.3% |
| Death |
4.1% |
| Respiratory Failure |
4.1% |
| Urinary Tract Infection |
4.0% |
| Femur Fracture |
3.7% |
| Renal Failure Acute |
3.7% |
| Rhabdomyolysis |
3.1% |
| Pulmonary Embolism |
3.0% |
| Gastric Cancer |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Pneumothorax |
2.9% |
| Weight Increased |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
47.2% |
| Polyarthritis |
11.8% |
| Arthritis |
5.5% |
| Bronchopulmonary Aspergillosis Allergic |
5.5% |
| Drug Use For Unknown Indication |
4.7% |
| Ill-defined Disorder |
4.7% |
| Pain |
3.9% |
| Back Pain |
3.1% |
| Bronchopulmonary Aspergillosis |
3.1% |
| Hip Arthroplasty |
1.6% |
| Hypertension |
1.6% |
| Abdominal Pain |
0.8% |
| Benign Neoplasm Of Prostate |
0.8% |
| Diabetes Mellitus |
0.8% |
| Hypercalcaemia |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Metastases To Meninges |
0.8% |
| Metastatic Malignant Melanoma |
0.8% |
| Musculoskeletal Pain |
0.8% |
| Neck Pain |
0.8% |
|
| Vomiting |
21.1% |
| Complement Factor Decreased |
7.9% |
| Drug Interaction |
7.9% |
| Mitral Valve Prolapse |
7.9% |
| Renal Failure Acute |
7.9% |
| Feeling Abnormal |
5.3% |
| Orthostatic Hypotension |
5.3% |
| Psychomotor Retardation |
5.3% |
| Anuria |
2.6% |
| Diarrhoea |
2.6% |
| Gastrointestinal Inflammation |
2.6% |
| Haemorrhage |
2.6% |
| Haemorrhoidal Haemorrhage |
2.6% |
| Melaena |
2.6% |
| Pancytopenia |
2.6% |
| Radiation Skin Injury |
2.6% |
| Respiratory Tract Haemorrhage |
2.6% |
| Salpingitis |
2.6% |
| Urogenital Haemorrhage |
2.6% |
| Water Intoxication |
2.6% |
|
